Osborne Clarke has advised Imperial Innovations Group plc on a £3 million funding round in Abingdon Health
16 Apr 2012
Osborne Clarke has advised Imperial Innovations Group plc on a £3 million funding round in Abingdon Health, a specialist medical diagnostics company.
Imperial led the round, which also included funding from private investors.
Abingdon will use the funds to take a controlling interest in disposable diagnostic device provider Molecular Vision, as well as investing in other projects.
The OC team advising Imperial was led by Private Equity partner Robert Wood.
Life Sciences in the news
Osborne Clarke's latest news stories
View our media page
to see all our latest news stories
View our publications page to see all our latest articles
Subscribe here for updates